Inflammatory bowel disease and the risk of fracture

Abitbol, 1995, Metabolic bone assessment in patients with inflammatory bowel disease, Gastroenterology, 108, 417, 10.1016/0016-5085(95)90068-3 Ardizzone, 2000, Altered bone metabolism in inflammatory bowel disease, J Intern Med, 247, 63, 10.1046/j.1365-2796.2000.00582.x Bernstein, 1995, Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis, J Bone Miner Res, 10, 250, 10.1002/jbmr.5650100211 Bernstein, 2000, The incidence of fracture among patients with inflammatory bowel disease, Ann Intern Med, 133, 795, 10.7326/0003-4819-133-10-200011210-00012 Bischoff, 1997, Altered bone metabolism in inflammatory bowel disease, Am J Gastroenterol, 92, 1157 Bjarnason, 1997, Reduced bone density in patients with inflammatory bowel disease, Gut, 40, 228, 10.1136/gut.40.2.228 Clements, 1992, Longitudinal study of cortical bone loss in patients with inflammatory bowel disease, Scand J Gastroenterol, 27, 1055, 10.3109/00365529209028138 Compston, 1987, Osteoporosis in patients with inflammatory bowel disease, Gut, 28, 410, 10.1136/gut.28.4.410 Ghosh, 1994, Low bone mineral density in Crohn’s disease, but not in ulcerative colitis, at diagnosis, Gastroenterology, 107, 1031, 10.1016/0016-5085(94)90227-5 Jahnsen, 1997, Bone mineral density is reduced in patients with Crohn’s disease but not in patients with ulcerative colitis, Gut, 40, 313, 10.1136/gut.40.3.313 Javaid, 2001, Comparison of calcaneal ultrasound and DXA to assess the risk of corticosteroid-induced osteoporosis, Osteoporos Int, 12, 788, 10.1007/s001980170056 Motley, 1993, A four-year longitudinal study of bone loss in patients with inflammatory bowel disease, Bone Miner, 23, 95, 10.1016/S0169-6009(08)80046-3 Pigot, 1992, Low bone mineral density in patients with inflammatory bowel disease, Dig Dis Sci, 37, 1396, 10.1007/BF01296010 Pollak, 1998, Femoral neck ostepenia in patients with inflammatory bowel disease, Am J Gastroenterol, 93, 1483, 10.1111/j.1572-0241.1998.468_q.x Robinson, 1998, Osteoporosis and determinants of bone density in patients with Crohn’s disease, Dig Dis Sci, 43, 2500, 10.1023/A:1026650719552 Schoon, 2000, Bone mineral density in patients with recently diagnosed inflammatory bowel disease, Gastroenterology, 119, 1203, 10.1053/gast.2000.19280 Schoon, 2000, Osteopenia and osteoporosis in Crohn’s disease, Scand J Gastroenterol, 43 Schulte, 1998, Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease, Inflamm Bowel Dis, 4, 268, 10.1002/ibd.3780040403 Silvennoinen, 1995, A controlled study of bone mineral density in patients with inflammatory bowel disease, Gut, 37, 71, 10.1136/gut.37.1.71 Tromm, 1994, Osteopenia in chronic inflammatory bowel diseases, Leber Magen Darm, 24, 23 Ulivieri, 2001, Bone mineral density and body composition in ulcerative colitis, Osteoporos Int, 12, 343, 10.1007/s001980170100 Vestergaard, 2000, Fracture risk is increased in Crohn’s disease, but not in ulcerative colitis, Gut, 46, 176, 10.1136/gut.46.2.176 Vestergaard, 2002, Fracture risk in patients with celiac disease, Crohn’s disease, and ulcerative colitis, Am J Epidemiol, 156, 1, 10.1093/aje/kwf007 Von Tirpitz, 1999, Pathological bone density in chronic inflammatory bowel diseases—prevalence and risk factors, Z Gastroenterol, 37, 5 Schoon, 1999, Osteoporosis as a risk in inflammatory bowel disease, Drugs Today, 35, 17 Van Staa, 2000, Use of oral corticosteroids and risk of fractures, J Bone Miner Res, 15, 1001, 10.1359/jbmr.2000.15.6.993 Van Staa, 2002, The epidemiology of corticosteroid-induced osteoporosis—a meta-analysis, Osteoporos Int, 13, 777, 10.1007/s001980200108 Walley, 1997, The UK General Practice Research Database, Lancet, 350, 1097, 10.1016/S0140-6736(97)04248-7 Van Staa, 1994, The quality of information recorded on a UK database of primary care records, Pharmacoepidemiol Drug Saf, 3, 15, 10.1002/pds.2630030106 Lewis, 2002, Validity and completeness of the general practice research database for studies of inflammatory bowel disease, Pharmacoepidemiol Drug Saf, 11, 211, 10.1002/pds.698 Rubin, 2000, Inflammatory bowel disease, Aliment Pharmacol Ther, 14, 1553, 10.1046/j.1365-2036.2000.00886.x Van Staa, 2001, The epidemiology of fractures in England and Wales, Bone, 29, 517, 10.1016/S8756-3282(01)00614-7 Sylvester, 2002, Effect of Crohn’s disease on bone metabolism in vitro, J Bone Miner Res, 17, 695, 10.1359/jbmr.2002.17.4.695 Cooper, 1993, The epidemiology of vertebral fractures. European Vertebral Osteoporosis Study Group, Bone, 14, 589, 10.1016/8756-3282(93)90358-H Klaus, 2002, High prevalence of osteoporotic vertebral fractures in patients with Crohn’s disease, Gut, 51, 654, 10.1136/gut.51.5.654 Stockbrügger, 2002, Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn’s disease, Aliment Pharmacol Ther, 16, 1519, 10.1046/j.1365-2036.2002.01317.x Loftus, 2002, Long-term fracture risk in patients with Crohn’s disease, Gastroenterology, 123, 468, 10.1053/gast.2002.34779 Hyams, 1997, Alterations in bone metabolism in children with inflammatory bowel disease, J Pediatr Gastroenterol Nutr, 24, 289, 10.1097/00005176-199703000-00011 Van Staa, 2000, The use of a large pharmaco-epidemiological database to study exposure to oral corticosteroids and risk of fractures, Pharmacoepidemiol Drug Saf, 9, 359, 10.1002/1099-1557(200009/10)9:5<359::AID-PDS507>3.0.CO;2-E 2003, American Gastroenterological Association medical position statement, Gastroenterology, 124, 791, 10.1053/gast.2003.50107